secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definium Therapeutics, Inc. (DFTX)
CIK:        0001813814
Form:       8-K
Filed at:   2024-04-01T23:59:59+00:00
Accession:  0000950170-24-039484
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MindMed voluntarily delists from Cboe Canada effective April 10, 2024; continues Nasdaq listing
--------------------------------------------------------------------------------

- Voluntary delisting from Cboe Canada at market close on April 10, 2024; Cboe Canada accepted notice.
- Common shares to continue trading on Nasdaq under symbol MNMD; ~95% of trading volume already on Nasdaq.
- Company cites insufficient Cboe Canada volume to justify dual listing costs; savings redirected to shareholder initiatives.
- Board approved delisting; no shareholder approval required as alternative market exists on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1813814/000095017024039484/0000950170-24-039484-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1813814/000095017024039484/mnmd-20240401.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-039484

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer